Si. Deutsch et al., ENVIRONMENTAL STRESS-INDUCED FUNCTIONAL MODIFICATION OF THE CENTRAL BENZODIAZEPINE BINDING-SITE, Clinical neuropharmacology, 17(3), 1994, pp. 205-228
The central benzodiazepine binding site mediates the therapeutically r
elevant pharmacologic actions of benzodiazepine agonists, including re
ducing anxiety, sedation, muscle relaxation, and antagonism of seizure
production. Benzodiazepines potentiate the ability of gamma-aminobuty
ric acid (GABA) to promote membrane chloride ion conductance by bindin
g reversibly to a distinct site on the GABA(A) receptor complex. Altho
ugh the role of this central benzodiazepine binding site in mediating
the pharmacologic actions of benzodiazepine agonists has been shown co
nclusively, its participation in an animal's response to stress is les
s certain. Data are reviewed consistent with an environmental stress-i
nduced modification of the structure and function of the central benzo
diazepine binding site. Modifications show brain anatomic regional sel
ectivity. The mechanisms of these modifications include rapid enzyme-m
ediated phosphorylations of the GABA(A) receptor complex and the selec
tive transcription of individual polypeptide subunits. The potential r
elevance of the data on environmental stress-induced functional modifi
cations of the central benzodiazepine binding site to the development
of newer medications and improved understanding of the pathophysiology
of stress-related neuropsychiatric disorders is discussed.